Autonomix Medical (AMIX) Non-Current Debt (2023)

Autonomix Medical's (AMIX) quarterly Non-Current Debt came in at $1.5 million in Q4 2023.

Autonomix Medical (AMIX) Non-Current Debt (2023) Analysis & Trends

Autonomix Medical (AMIX) has 1 years of Non-Current Debt data on file, last reported at $1.5 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 184.32 Bn 177.02 Bn 6.27 Bn 29.64 Bn
2 Stryker 128.89 Bn 126.01 Bn 3.81 Bn 14.22 Bn
3 Medtronic 108.88 Bn 99.66 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 68.65 Bn 67.20 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 47.43 Bn 43.76 Bn 1.29 Bn 598.50 Mn
6 GE HealthCare Technologies 28.48 Bn 26.19 Bn 1.98 Bn 10.13 Bn
7 Dexcom 28.45 Bn 27.33 Bn 750.30 Mn -
8 Smith & Nephew 26.98 Bn 26.40 Bn - 3.18 Bn
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn 8.07 Bn
10 Autonomix Medical 1.29 Mn 1.29 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.46 Mn